[HTML][HTML] Neuron-astrocyte interactions in Parkinson's disease
I Miyazaki, M Asanuma - Cells, 2020 - mdpi.com
Parkinson's disease (PD) is the second most common neurodegenerative disease. PD
patients exhibit motor symptoms such as akinesia/bradykinesia, tremor, rigidity, and postural …
patients exhibit motor symptoms such as akinesia/bradykinesia, tremor, rigidity, and postural …
Fluid biomarkers for synaptic dysfunction and loss
E Camporesi, J Nilsson, A Brinkmalm… - Biomarker …, 2020 - journals.sagepub.com
Synapses are the site for brain communication where information is transmitted between
neurons and stored for memory formation. Synaptic degeneration is a global and early …
neurons and stored for memory formation. Synaptic degeneration is a global and early …
[HTML][HTML] Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration
Microglia maintain brain homeostasis by removing neuron-derived components such as
myelin and cell debris. The evidence linking microglia to neurodegenerative diseases is …
myelin and cell debris. The evidence linking microglia to neurodegenerative diseases is …
The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration
AL Mahul-Mellier, J Burtscher… - Proceedings of the …, 2020 - National Acad Sciences
Parkinson's disease (PD) is characterized by the accumulation of misfolded and aggregated
α-synuclein (α-syn) into intraneuronal inclusions named Lewy bodies (LBs). Although it is …
α-synuclein (α-syn) into intraneuronal inclusions named Lewy bodies (LBs). Although it is …
[HTML][HTML] How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using …
ST Kumar, S Jagannath, C Francois… - Neurobiology of …, 2020 - Elsevier
Increasing evidence suggests that alpha-synuclein (α-syn) oligomers are obligate
intermediates in the pathway involved in α-syn fibrillization and Lewy body (LB) formation …
intermediates in the pathway involved in α-syn fibrillization and Lewy body (LB) formation …
[HTML][HTML] The emerging role of α-synuclein truncation in aggregation and disease
ZA Sorrentino, BI Giasson - Journal of Biological Chemistry, 2020 - ASBMB
α-Synuclein (αsyn) is an abundant brain neuronal protein that can misfold and polymerize to
form toxic fibrils coalescing into pathologic inclusions in neurodegenerative diseases …
form toxic fibrils coalescing into pathologic inclusions in neurodegenerative diseases …
[HTML][HTML] Do post-translational modifications influence protein aggregation in neurodegenerative diseases: a systematic review
LN Schaffert, WG Carter - Brain sciences, 2020 - mdpi.com
The accumulation of abnormal protein aggregates represents a universal hallmark of
neurodegenerative diseases (NDDs). Post-translational modifications (PTMs) regulate …
neurodegenerative diseases (NDDs). Post-translational modifications (PTMs) regulate …
[HTML][HTML] Glucocerebrosidase activity modulates neuronal susceptibility to pathological α-synuclein insult
Mutations in the GBA1 gene are the most common genetic risk factor for Parkinson's disease
(PD) and dementia with Lewy bodies (DLB). GBA1 encodes the lysosomal lipid hydrolase …
(PD) and dementia with Lewy bodies (DLB). GBA1 encodes the lysosomal lipid hydrolase …
[HTML][HTML] Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports
HA Lashuel - Neurobiology of disease, 2020 - Elsevier
Several lines of evidence from neuropathological studies, human genetics, in vitro
aggregation studies and cellular and animal models support the hypothesis that aSyn plays …
aggregation studies and cellular and animal models support the hypothesis that aSyn plays …
Salivary microR‐153 and microR‐223 levels as potential diagnostic biomarkers of idiopathic Parkinson's disease
M Cressatti, L Juwara, JM Galindez… - Movement …, 2020 - Wiley Online Library
Background Parkinson's disease (PD) is the most common movement disorder among
adults, affecting 2% of the world population older than 65 years of age. No diagnostic …
adults, affecting 2% of the world population older than 65 years of age. No diagnostic …